» Articles » PMID: 26814675

Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data--The Influence of Different Parameters in a Routine Clinical Microbiology Laboratory

Overview
Journal PLoS One
Date 2016 Jan 28
PMID 26814675
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Many clinical microbiology laboratories report on cumulative antimicrobial susceptibility testing (cAST) data on a regular basis. Criteria for generation of cAST reports, however, are often obscure and inconsistent. Whereas the CLSI has published a guideline for analysis and presentation of cAST data, national guidelines directed at clinical microbiology laboratories are not available in Europe. Thus, we sought to describe the influence of different parameters in the process of cAST data analysis in the setting of a German routine clinical microbiology laboratory during 2 consecutive years.

Material And Methods: We developed various program scripts to assess the consequences ensuing from different algorithms for calculation of cumulative antibiograms from the data collected in our clinical microbiology laboratory in 2013 and 2014.

Results: One of the most pronounced effects was caused by exclusion of screening cultures for multi-drug resistant organisms which decreased the MRSA rate in some cases to one third. Dependent on the handling of duplicate isolates, i.e. isolates of the same species recovered from successive cultures on the same patient during the time period analyzed, we recorded differences in resistance rates of up to 5 percentage points for S. aureus, E. coli and K. pneumoniae and up to 10 percentage points for P. aeruginosa. Stratification by site of care and specimen type, testing of antimicrobials selectively on resistant isolates, change of interpretation rules and analysis at genus level instead of species level resulted in further changes of calculated antimicrobial resistance rates.

Conclusion: The choice of parameters for cAST data analysis may have a substantial influence on calculated antimicrobial resistance rates. Consequently, comparability of cAST reports from different clinical microbiology laboratories may be limited. We suggest that laboratories communicate the strategy used for cAST data analysis as long as national guidelines for standardized cAST data analysis and reporting do not exist in Europe.

Citing Articles

Microbiological Profiles and Resistance Patterns in Pediatrics With Cancer: An 8-Year Study at a Comprehensive Cancer Center in Jordan.

Hassouneh D, Zatarah R, AbuSara A, Nazer L, Abu Ghosh A, Aryan H Cancer Rep (Hoboken). 2025; 8(3):e70132.

PMID: 40065500 PMC: 11893483. DOI: 10.1002/cnr2.70132.


Drug combinations targeting antibiotic resistance.

Bognar B, Spohn R, Lazar V NPJ Antimicrob Resist. 2025; 2(1):29.

PMID: 39843924 PMC: 11721080. DOI: 10.1038/s44259-024-00047-2.


Change in Klebsiella pneumoniae susceptibility profile after the arrival of ceftazidime-avibactam in an Argentinean intensive care unit: a new ecological landscape.

Favier P, Abusamra L, Moncalero S, Errecalde L, Montibello S, Rodriguez O Rev Esp Quimioter. 2024; 37(5):415-421.

PMID: 38957944 PMC: 11462321. DOI: 10.37201/req/042.2024.


Implications of deduplication on the detection rates of multidrug-resistant organism (MDRO) in various specimens: insights from the hospital infection surveillance program.

Li Z, Zhu D, Ma X, Zang F, Zhang W, Luo C Antimicrob Resist Infect Control. 2024; 13(1):54.

PMID: 38769515 PMC: 11107067. DOI: 10.1186/s13756-024-01408-2.


Diagnostic Accuracy of Hospital Antibiograms in Predicting the Risk of Antimicrobial Resistance in Enterobacteriaceae Isolates: A Nationwide Multicenter Evaluation at the Veterans Health Administration.

Hasegawa S, Livorsi D, Perencevich E, Church J, Goto M Clin Infect Dis. 2023; 77(11):1492-1500.

PMID: 37658908 PMC: 11487110. DOI: 10.1093/cid/ciad467.


References
1.
Laupland K, Ross T, Pitout J, Church D, Gregson D . Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistance. Clin Invest Med. 2007; 30(4):E159-66. DOI: 10.25011/cim.v30i4.1777. View

2.
Alvarez-Paredes L, Lopez-Riquelme N, Rodriguez J, Santibanez M, Belda S, Galiana A . Prevalence of methicillin-resistant Staphylococcus aureus : effect of different criteria for elimination of duplicates. Chemotherapy. 2014; 59(6):453-7. DOI: 10.1159/000362785. View

3.
Cornaglia G, Hryniewicz W, Jarlier V, Kahlmeter G, Mittermayer H, Stratchounski L . European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect. 2004; 10(4):349-83. DOI: 10.1111/j.1198-743X.2004.00887.x. View

4.
Kuster S, Ruef C, Zbinden R, Gottschalk J, Ledergerber B, Neuber L . Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay. J Antimicrob Chemother. 2008; 62(6):1451-61. DOI: 10.1093/jac/dkn384. View

5.
Weber S, Miller R, Perencevich E, Tolentino J, Meltzer D, Pitrak D . Prevalence of antimicrobial-resistant bacteria isolated from older versus younger hospitalized adults: results of a two-centre study. J Antimicrob Chemother. 2009; 64(6):1291-8. PMC: 2775664. DOI: 10.1093/jac/dkp349. View